openPR Logo
Press release

Poor Lifestyle Choices Driving Growth in Nephrology Drugs Market

11-13-2024 11:57 AM CET | Health & Medicine

Press release from: Allied Market Research

Nephrology Drugs Market

Nephrology Drugs Market

𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.alliedmarketresearch.com/nephrology-drugs-market-A13396

The global nephrology drugs market has shown a strong growth trajectory, with a valuation of $14,501.75 million in 2020, and it is projected to reach $23,405.42 million by 2030. This growth represents a compound annual growth rate (CAGR) of 5.0% from 2021 to 2030. A variety of factors contribute to the expansion of this market, ranging from rising cases of kidney failure to advancements in renal treatments and emerging technologies.

Key Drivers of Market Growth:

• Increase in Kidney Failure Cases: Rising prevalence of chronic kidney diseases (CKD) and kidney failure is a major factor propelling the demand for nephrology drugs.
• Adoption of Unhealthy Lifestyles: Poor lifestyle choices such as lack of physical activity, excessive alcohol consumption, and poor diet are contributing to kidney-related disorders.
• Rising Geriatric Population: The growing number of elderly people, who are at higher risk for kidney diseases, is another significant driver.
• Demand for Diagnostic Tests: Increased awareness and use of diagnostic tools contribute to early-stage detection of kidney diseases, boosting the demand for nephrology treatments.
• Prevalence of Obesity: Obesity-related nephrological conditions, such as hypertension and diabetes, are also driving the demand for targeted drug therapies.
Factors Supporting Market Expansion:
• Technological Advancements in Developing Countries: Emerging markets are witnessing advancements in healthcare infrastructure and diagnostic technologies, creating opportunities for the nephrology drugs market.
• R&D in Renal Drug Development: A strong focus on research and development is leading to the introduction of novel drugs and improved treatment options for nephrological conditions.
• Growth of Immunotherapies and Targeted Therapies: The rise in demand for these therapies has also been a major boost for the nephrology drugs market.
• Strategic Collaborations: Partnerships, joint ventures, and agreements between key pharmaceutical players further enhance the market outlook.
Market Challenges:
• High Treatment Costs: The expensive nature of advanced nephrology treatments may limit access in low-income regions.
• Lack of Awareness: The lack of knowledge about kidney disorders, especially in rural areas, may hinder the growth of the market.
Opportunities for Market Growth:
• Government Initiatives: Regulatory approvals and favorable insurance policies are expected to open up new opportunities for market expansion, particularly in regions with growing healthcare investments.

Key Nephrology Drugs:
Nephron, the essential unit for filtration in the kidneys, is often impacted by conditions such as diabetes and hypertension, leading to chronic kidney disorders. Some common drugs used in nephrology include:
• Invokana
• Phoslo
• Renvela
• Sensipar
• Procrit

Nephrology Drugs Market Segmentation:
By Drug Class:
• ACE Inhibitors: Dominating the market due to the rising prevalence of hypertension and cardiovascular diseases.
• Calcium Channel Blockers
• Beta Blockers
• Diuretics
• Erythropoiesis-Stimulating Agents
• Others
By Route of Administration:
• Oral: This segment dominated the market in 2020 due to novel drug launches.
• Parenteral
• Others
By Distribution Channel:
• Retail Pharmacies: Leading the market in 2020, driven by improvements in medical infrastructure and public healthcare expenditure.
• Hospital Pharmacies
• Online Pharmacies

By Region:
• North America: The dominant region in 2020, due to higher awareness of chronic kidney diseases and advanced healthcare systems.
• Asia-Pacific: Expected to witness rapid growth due to increased healthcare access, rising kidney disease rates, and significant investment in drug manufacturing.
• Europe
• LAMEA (Latin America, Middle East, and Africa)

Key Market Players:
The nephrology drugs market is competitive, with several key players driving innovation and market expansion:
• AstraZeneca
• AbbVie Inc.
• Akebia Therapeutics, Inc.
• Amgen Inc.
• F. Hoffmann-La Roche
• FibroGen Inc.
• GlaxoSmithKline PLC.
• Johnson & Johnson Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Limited
These companies are actively engaging in product launches, collaborations, and partnerships to strengthen their market presence.
________________________________________
Conclusion:
The nephrology drugs market is poised for significant growth, driven by a variety of factors including the rising prevalence of kidney diseases, advancements in medical treatments, and the increasing demand for diagnostic solutions. However, challenges such as high treatment costs and a lack of awareness in certain regions still need to be addressed. Continued innovation and strategic initiatives from key players will play a pivotal role in shaping the future of this market.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A13396

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises and medium and small businesses with unmatched quality of "Market Research Reports Insights" and "Business Intelligence Solutions." AMR aims to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Poor Lifestyle Choices Driving Growth in Nephrology Drugs Market here

News-ID: 3733216 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase